Trial intelligence / Profile preview

Dexmedetomidine vs placebo effect on sleep quality in mechanically ventilated critically ill ICU patients

2017-001612-11Phase 4Completed

Sponsor
Capital Region of Denmark
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in sleep disorders secondary to medical conditions, critical illness and None comparing Dexdor (dexmedetomidine) with Placebo (2 arms). Primary endpoint: Deep sleep / sleep quality (slow-wave activity by PSG). Started Oct 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

sleep disorders secondary to medical conditionscritical illness

Beyond the preview

Go deeper on 2017-001612-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001612-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call